← Back to Search

Robot Therapy

Robot Therapy for Stroke

N/A
Waitlist Available
Led By Michelle J Johnson, PhD
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Stroke (at least 3 months post incident) with or without HIV, age over 18
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at week 8
Awards & highlights

Study Summary

This trial tests the feasibility of using an affordable robot for rehabilitation therapy for people with HIV who have experienced a stroke.

Who is the study for?
This trial is for adults over 18 in Botswana who've had a stroke and are living with or without HIV. They should have moderate neurological function and cognitive ability, be medically stable to handle therapy, and able to consent. People with severe drug/alcohol abuse, depression, excessive pain, extreme spasticity or paralysis, psychiatric or cardiac issues, prior brain injury or open lesions can't join.Check my eligibility
What is being tested?
The study is exploring the use of affordable robot-assisted rehabilitation combined with mobile health technologies for people in Botswana who have suffered a stroke associated with HIV. It aims to test if this approach is feasible and effective in improving their functional outcomes.See study design
What are the potential side effects?
Since this trial involves physical rehabilitation using robots rather than medication, side effects may include muscle soreness or fatigue from therapy sessions. However specific side effects will depend on individual conditions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I had a stroke at least 3 months ago and am over 18.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at week 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and at week 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline assessment of # of blocks that can be grasped and moved
Change from baseline assessment of 10 Meter Walk Test
Change from baseline assessment of Timed up and go
+5 more

Side effects data

From 2015 Phase 1 & 2 trial • 59 Patients • NCT01253018
9%
Hospitalization to r/o new CVA
9%
Fall at home with resulting fx to study arm
5%
Seizure
5%
Atrial Fib
100%
80%
60%
40%
20%
0%
Study treatment Arm
Transition to Task Training
Robot Therapy

Trial Design

2Treatment groups
Experimental Treatment
Group I: Stroke survivorsExperimental Treatment1 Intervention
Stroke survivors greater than 18 years of age with hemiplegia with and without HIV/AIDS.
Group II: Low-to-mid functioning HIV/AIDS patientsExperimental Treatment1 Intervention
Low-to-mid functioning HIV/AIDS patients greater than 18 years of age with stroke co-morbidity.

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
1,992 Previous Clinical Trials
42,875,330 Total Patients Enrolled
29 Trials studying Stroke
2,171 Patients Enrolled for Stroke
Michelle J Johnson, PhDPrincipal InvestigatorUniversity of Pennsylvania
11 Previous Clinical Trials
2,031 Total Patients Enrolled
9 Trials studying Stroke
278 Patients Enrolled for Stroke

Media Library

Robot Therapy (Robot Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT04488250 — N/A
Stroke Research Study Groups: Stroke survivors, Low-to-mid functioning HIV/AIDS patients
Stroke Clinical Trial 2023: Robot Therapy Highlights & Side Effects. Trial Name: NCT04488250 — N/A
Robot Therapy (Robot Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04488250 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there an opportunity to join this scientific experiment?

"This clinical trial requires 30 stroke patients with ages ranging from 18 to 90. Essential requirements include a diagnosis of Stroke (at least 3 months post incident) with or without HIV, an NIHSS score between 5 and 24, moderate cognitive function as defined by the International HIV-Dementia Scale, medical stability sufficient for participation in therapy, and consenting capacity."

Answered by AI

Does this experiment currently admit new participants?

"According to the details on clinicaltrials.gov, this research is actively enrolling participants. The trail was initially published on October 1st 2019 and has been revised as recently as December 1st 2022."

Answered by AI

Does the eligibility criteria for this study encompass individuals under 20 years of age?

"As per this clinical trial's admittance requirements, the minimum age of recruitment is 18 years old and the maximum permissible age is 90."

Answered by AI
~2 spots leftby Aug 2024